Published in Health and Medicine Week, April 20th, 2006
"One evolving approach to improved prognostication of cancer patients is the identification of previously occult disease by use of quantitative reverse transcription-PCR. Surprisingly, no systematic analysis of potential mRNA markers for colorectal cancer has been reported," researchers in the United States reported.
"We therefore performed an extensive mRNA marker survey for colorectal cancers," explained L.Q. Xi and colleagues, University of Pittsburgh. "We identified potential markers through literature and database searches. We analyzed all markers by quantitative reverse transcription-PCR on a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.